Taiko Pharmaceutical: Confirmation letter
Taiko Pharmaceutical: Quarterly Report - 79th Quarter 1 (2024/01/01 to 2024/03/31)
Taiko Pharmaceutical: Summary of financial results for the 1st quarter of 2024
Taiko Pharmaceutical: Consolidated financial results report for the 1st quarter of the fiscal year ending 2024/12 (FY2024)
Taiko Pharmaceutical: Summary of financial results for the 1st quarter of the fiscal year ending 2024/12 [Japanese GAAP] (consolidated)
Taiko Pharmaceutical: Notice regarding completion of payment of disposal of treasury stock as stock reward with transfer restrictions
Taiko Pharmaceutical: Corporate Governance Report 2024/04/12
Taiko Pharmaceutical: Extraordinary Report
Taiko Pharmaceutical: Notice regarding disposal of treasury stock as share compensation with transfer restrictions
Taiko Pharmaceutical: Internal Control Report - 78th Term (2023/01/01 - 2023/12/31)
Taiko Pharmaceutical: Confirmation
Taiko Pharmaceutical: Financial Report - 78th Term (2023/01/01 - 2023/12/31)
Taiko Pharmaceutical: Plans for compliance with listing maintenance standards
Taiko Pharmaceutical: Notice Concerning the Recording of Special Profit and Revision of Consolidated Earnings Forecasts
Taiko Pharmaceutical: Independent Officer Registration Form
Taiko Pharmaceutical: Notice of Convocation of 2024 Annual General Meeting of Shareholders
Taiko Pharmaceutical: Notice regarding changes in officers
Taiko Pharmaceutical: Notice regarding a decrease in the amount of capital (capital reduction)
Taiko Pharmaceutical: Consolidated financial results report for the fiscal year ending 2023/12 (FY2023)
Taiko Pharmaceutical: Extraordinary Report
No Data